Product Images Cisatracurium Besylate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Cisatracurium Besylate NDC 71288-720 by Meitheal Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Principal Display Panel – Cisatracurium Besylate Injection, USP Carton - cis vizient carton

Principal Display Panel – Cisatracurium Besylate Injection, USP Carton - cis vizient carton

Cisatracurium Besylate Injection is a paralyzing agent used for intravenous injection. It is available in single-dose vials containing 2mg per mL of Cisatracurium. This medication contains benzenesulfonic acid and should be refrigerated between 2°C and 8°C (36 and 46°F) in its carton. It is important to have respiratory support facilities readily available when administering this medication. For complete prescription information, refer to the package insert. The product does not contain natural rubber latex. Contact the manufacturer for more information.*

Figure 1 - cis vizient fig1

Figure 1 - cis vizient fig1

Figure 2 - cis vizient fig2

Figure 2 - cis vizient fig2

structural formula - cis vizient struct

structural formula - cis vizient struct

Principal Display Panel – Cisatracurium Besylate Injection, USP Vial Label - cis vizient vial

Principal Display Panel – Cisatracurium Besylate Injection, USP Vial Label - cis vizient vial

Warning: This product is a paralyzing agent and can cause respiratory arrest. It is recommended that facilities have artificial respiration immediately available. The product is manufactured by Meitheal Pharmaceuticals and is for intravenous injection. It should be discarded within 21 days of being removed from refrigeration, even if refrigerated. The product contains Besylate Injection, USP, which is a registered trademark of Novapls. Cisatracurium is also listed as an ingredient.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.